Use of Proteomics to Explore Biomarkers of Amyotrophic Lateral Sclerosis (ALS): Proof of Principle from Humanized SOD1 Mouse to Human ALS

肌萎缩侧索硬化 SOD1 医学 蛋白质组学 概念证明 临床前研究 神经科学 生物 疾病 病理 计算机科学 生物化学 基因 操作系统
作者
Nitesh Sanghai,Geoffrey K. Tranmer
出处
期刊:ACS pharmacology & translational science [American Chemical Society]
卷期号:8 (8): 2415-2430
标识
DOI:10.1021/acsptsci.5c00403
摘要

Amyotrophic lateral sclerosis (ALS) is a rare motor neurodegenerative disease affecting multiple cellular proteins during the progression of the disease. ALS was first discovered by Charcot in 1869, and since then, scientists have been unable to identify a singular cause of the disease. Further, there are no effective treatments available to cure ALS. The benchmark discovery of humanized preclinical SOD1 mouse models, which recapitulates the clinical and pathological phenotypes of human ALS, gives hope to medicinal chemists and neuroscientists around the globe that a suitable drug-like molecule can be discovered and translated into human beings as a means to slow down the progression of the disease. However, little success has been achieved until now in terms of finding an effective treatment for heterogenic and incurable ALS. One area marked for improvement is the use of semiquantitative, antibody-based targeted Western blotting (WB) experiments, which lack the power to analyze multiple cellular events within the entire dysregulated proteomic system. With the inconsistency of WB experiments, unexpected cellular pathways go undiscovered, and hence, loss of translation with no target engagement is seen from preclinical to human clinical ALS. Recent advancements in discovery-based quantitative proteomics have many advantages over WB. These innovative techniques could help solve the inherent problem in WB and their inability to discover multiple altered proteins with the added capability of longitudinal analysis in preclinical SOD1 models, further validating the findings in human ALS. Herein, we applied a holistic approach to summarize various reports on the use of proteomics in ALS from the published literature, and importantly, we found that using a discovery-based proteomics approach in SOD1 preclinical ALS models has revealed a more diverse and global picture of pathological proteins that affect multiple pathways during different stages of disease progression. Furthermore, we found that the proteomic profiling of the humanized SOD1 mouse model provided a proof of principle for translating the diverse pathological biomarker proteins identified in clinical human ALS cases. Moreover, we believe that advancements in the proteomics approach toward ALS biomarkers could bridge the gap between preclinical and clinical studies, enabling scientists worldwide to discover novel biomarkers and treatments that modify the progression of ALS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
想杀鸡发布了新的文献求助10
1秒前
邹国嵩完成签到,获得积分10
1秒前
无限完成签到 ,获得积分10
1秒前
MRCHONG发布了新的文献求助10
1秒前
小SCI发布了新的文献求助10
2秒前
hhhhh发布了新的文献求助10
2秒前
科研通AI6.2的应助被雅风采纳,获得10
2秒前
领导范儿的应助被lzq采纳,获得10
3秒前
檀兮尔发布了新的文献求助10
3秒前
深情安青的应助被许右采纳,获得10
4秒前
4秒前
4秒前
余又发布了新的文献求助10
4秒前
4秒前
shery完成签到,获得积分10
5秒前
5秒前
王jyk发布了新的文献求助10
5秒前
搜集达人的应助被sun采纳,获得10
6秒前
阿啊啊完成签到,获得积分10
7秒前
7秒前
酷波er的应助被千里洛采纳,获得10
7秒前
8秒前
落羽发布了新的文献求助10
8秒前
8秒前
cc完成签到,获得积分0
9秒前
募雨qaq发布了新的文献求助10
9秒前
啦啦啦完成签到,获得积分20
9秒前
9秒前
10秒前
思源的应助被elysia采纳,获得30
10秒前
10秒前
10秒前
10秒前
oosr发布了新的文献求助10
11秒前
11秒前
pp发布了新的文献求助10
11秒前
IceyCNZ发布了新的文献求助10
11秒前
初(*^▽^*)心的应助被哭泣冬瓜采纳,获得10
12秒前
酷波er的应助被檀兮尔采纳,获得10
12秒前
Czz发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611